| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 96,850 | 144,839 | 146,919 | 117,758 | | Cost of Revenue | 67,214 | 102,479 | 108,234 | 91,925 | | | Gross Profit | 29,636 | 42,360 | 38,685 | 25,833 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 13,205 | 12,605 | 13,303 | 10,055 | | Non Recurring | (736) | 543 | 193 | 366 | | Others | 16,314 | 12,868 | 12,496 | 13,275 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,289) | 16,344 | 12,693 | 2,137 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (865) | 302 | 110 | 657 | | Earnings Before Interest And Taxes | (12) | 16,646 | 12,803 | 2,794 | | Interest Expense | 1,244 | 1,671 | 1,611 | 1,982 | | Income Before Tax | (1,256) | 14,975 | 11,192 | 812 | | Income Tax Expense | 1,482 | 11,592 | 5,206 | 5,122 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,738) | 3,383 | 5,986 | (4,310) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,738) | 3,383 | 5,986 | (4,310) | | Preferred Stock And Other Adjustments | (2,106) | (2,066) | (2,027) | (1,982) | | | Net Income Applicable To Common Shares | ($4,844) | $1,317 | $3,959 | ($6,292) |
|
0.20% Nasdaq 
Income Statement
